The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Relationship Between the HLA-B*1502 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis
Abstract
IMPORTANCE: The US Food and Drug Administration recommends screening for the HLA-B*1502 allele before initiation of carbamazepine therapy in patients of Asian ancestry, but there remains unclear evidence of a relationship between HLA-B*1502 and Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) among carbamazepine users, especially in some racial/ethnic populations. OBJECTIVE: To determine the relationship between the HLA-B*1502 allele and carbamazepine-induced SJS and TEN. DATA SOURCES: A comprehensive search of the following data sources was performed without language restriction from the inception of the database until January 8, 2013: EMBASE, PubMed, clinicaltrials.gov, Cochrane Library, IPA (International Pharmaceutical Abstracts), HuGENet (Human Genome Epidemiology Network), and CINAHL (Cumulative Index to Nursing and Allied Health Literature), and the reference lists of identified studies. STUDY SELECTION: Inclusion criteria were studies that investigated the relationship between HLA-B*1502 and carbamazepine-induced SJS and TEN and that reported sufficient data for calculating the frequency of HLA-B*1502 carriers among cases and controls. The search yielded 525 articles, of which 16 met the inclusion criteria. The studies included 227 SJS or TEN cases, 602 matched control subjects, and 2949 population control subjects. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted the following data: study design, eligibility criteria, diagnostic criteria, patient demographics, genotype distribution, HLA-B genotyping technique, selection of cases and controls, dosage of carbamazepine and duration of use, and results of Hardy-Weinberg equilibrium in the control group. The Newcastle-Ottawa Scale was used to assess the quality of studies. The overall odds ratios (ORs) with corresponding 95% CIs were calculated using a random-effects model. The primary analysis was based on matched control studies. Subgroup analyses by race/ethnicity were also performed. MAIN OUTCOME AND MEASURE: The primary outcome was carbamazepine-induced SJS and TEN. The outcome measure is given as an overall OR. RESULTS: The summary OR for the relationship between HLA-B*1502 and carbamazepine-induced SJS and TEN was 79.84 (95% CI, 28.45-224.06). Racial/ethnic subgroup analyses yielded similar findings for Han-Chinese (115.32; 18.17-732.13), Thais (54.43; 16.28-181.96), and Malaysians (221.00; 3.85-12 694.65). Among individuals of white or Japanese race/ethnicity, no patients with SJS or TEN were carriers of the HLA-B*1502 allele. CONCLUSIONS AND RELEVANCE: We found a strong relationship between the HLA-B*1502 allele and carbamazepine-induced SJS and TEN in Han-Chinese, Thai, and Malaysian populations. HLA-B*1502 screening in patients requiring carbamazepine therapy is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
(2014) · Medical Entomology and Zoology · Cited by 17,633
A marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Severe Adverse Cutaneous Reactions to Drugs
Roujeau, J. C., & Stern, R. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311906 · Cited by 1,571
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
meta-analysis bias in location and selection of studies
Egger, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7124.61 · Cited by 1,374
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
McCormack, M., Alfirevic, A., Bourgeois, S., Farrell, J. J., Kasperavičiūtė, D., Carrington, M., Sills, G. J., Marson, T., Jia, X., de Bakker, P. I. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013297 · Cited by 925
Gonzalez-Galarza, F. F., Christmas, S., Middleton, D., & Jones, A. R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1128 · Cited by 724
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Hung, S.-I., Chung, W.-H., Jee, S.-H., Chen, W.-C., Chang, Y.-T., Lee, W.-R., Hu, S.-L., Wu, M.-T., Chen, G.-S., Wong, T.-W., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000199500.46842.4a · Cited by 680
Lonjou, C., Borot, N., Sekula, P., Ledger, N., Thomas, L., Halevy, S., Naldi, L., Bouwes-Bavinck, J.-N., Sidoroff, A., de Toma, C., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f3ef9c · Cited by 624
A method for meta-analysis of molecular association studies
Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D., & Attia, J. (2005) · Statistics in Medicine · doi:10.1002/sim.2010 · Cited by 618
Ozeki, T., Mushiroda, T., Yowang, A., Takahashi, A., Kubo, M., Shirakata, Y., Ikezawa, Z., Iijima, M., Shiohara, T., Hashimoto, K., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq537 · Cited by 515
Man, C. B. L., Kwan, P., Baum, L., Yu, E., Lau, K. M., Cheng, A. S. H., & Ng, M. H. L. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01022.x · Cited by 507
Locharernkul, C., Loplumlert, J., Limotai, C., Korkij, W., Desudchit, T., Tongkobpetch, S., Kangwanshiratada, O., Hirankarn, N., Suphapeetiporn, K., & Shotelersuk, V. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01719.x · Cited by 482
Publication Bias and Dissemination of Clinical Research
Begg, C. B., & Berlin, J. A. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.107 · Cited by 440
Clinical heterogeneity of drug hypersensitivity
Roujeau, J.-C. (2005) · Toxicology · doi:10.1016/j.tox.2004.12.022 · Cited by 424
Kaniwa, N., Saito, Y., Aihara, M., Matsunaga, K., Tohkin, M., Kurose, K., Sawada, J.-I., Furuya, H., Takahashi, Y., Muramatsu, M., et al. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.11.1617 · Cited by 410
A marker for Stevens-Johnson syndrome …: ethnicity matters
Lonjou, C., Thomas, L., Borot, N., Ledger, N., de Toma, C., LeLouet, H., Graf, E., Schumacher, M., Hovnanian, A., Mockenhaupt, M., et al. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500356 · Cited by 401
Chan, H.-L. (1990) · Archives of Dermatology · doi:10.1001/archderm.1990.01670250049006 · Cited by 371
Genetic Structure of the Han Chinese Population Revealed by Genome-wide SNP Variation
Chen, J., Zheng, H., Bei, J.-X., Sun, L., Jia, W.-H., Li, T., Zhang, F., Seielstad, M., Zeng, Y.-X., Zhang, X., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.10.016 · Cited by 315
Ko, T.-M., Chung, W.-H., Wei, C.-Y., Shih, H.-Y., Chen, J.-K., Lin, C.-H., Chen, Y.-T., & Hung, S.-I. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.013 · Cited by 272
HLA-B Locus in Caucasian Patients with Carbamazepine hypersensitivity
Alfirevic, A., Jorgensen, A. L., Williamson, P. R., Chadwick, D. W., Park, B. K., & Pirmohamed, M. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.6.813 · Cited by 264
Somkrua, R., Eickman, E. E., Saokaew, S., Lohitnavy, M., & Chaiyakunapruk, N. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-118 · Cited by 219
Self-citationObstacles and opportunities in meta-analysis of genetic association studies
Salanti, G., Sanderson, S., & Higgins, J. P. T. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000151839.12032.1a · Cited by 196
A Century of Hardy–Weinberg Equilibrium
Mayo, O. (2008) · Twin Research and Human Genetics · doi:10.1375/twin.11.3.249 · Cited by 187
Drug Hypersensitivity and Human Leukocyte Antigens of the Major Histocompatibility Complex
Bharadwaj, M., Illing, P., Theodossis, A., Purcell, A. W., Rossjohn, J., & McCluskey, J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134701 · Cited by 162
Cox, D. R. (1970) · Biometrika · doi:10.1093/biomet/57.1.217 · Cited by 157
Zhang, Y., Wang, J., Zhao, L., Peng, W., Guo-qing, S., Xue, L., Xiao-xian, Z., Xiao-jing, H., Chun-yan, G., & Miao, L.-Y. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1009-4 · Cited by 132
Kulkantrakorn, K., Tassaneeyakul, W., Tiamkao, S., Jantararoungtong, T., Prabmeechai, N., Vannaprasaht, S., Chumworathayi, P., Chen, P., & Sritipsukho, P. (2011) · Pain Practice · doi:10.1111/j.1533-2500.2011.00479.x · Cited by 106
Self-citationKashiwagi, M., Aihara, M., Takahashi, Y., YAMAZAKI, E., YAMANE, Y., Song, Y., Muramatsu, M., & Ikezawa, Z. (2008) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2008.00548.x · Cited by 75
Kamaliah, M. D., Drcog, Zainal, D., Mbbs, Mokhtar, N., & Nazmi, N. (1998) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1998.00490.x · Cited by 68
The Continuity Correction in 2 × 2 Tables
Plackett, R. L. (1964) · Biometrika · doi:10.1093/biomet/51.3-4.327 · Cited by 61
A Recent Update of Pharmacogenomics in Drug-induced Severe Skin Reactions
Wei, C.-Y., Ko, T., Shen, C., & Chen, Y.-T. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rv-116 · Cited by 45
Genetic aspects of immune-mediated adverse drug effects
Bugelski, P. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1605 · Cited by 27
A review on the design and reporting of studies on drug–gene interaction
Smits, K. M., Schouten, J., Smits, L. J. M., Stelma, F. F., Nelemans, P. J., & Prins, M. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.001 · Cited by 24
Cited by
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature
Casagranda, A., Suppa, M., Dehavay, F., & del Marmol, V. (2017) · Case Reports in Dermatology · doi:10.1159/000475802 · Cited by 1,466
Mayorga, C., Celik, G., Rouzaire, P., Whitaker, P., Bonadonna, P., Rodrigues‐Cernadas, J., Vultaggio, A., Brockow, K., Caubet, J. C., Makowska, J., et al. (2016) · Allergy · doi:10.1111/all.12886 · Cited by 314
Hasty generalizations and generics in medical research: A systematic review
Peters, U., Sherling, H. R., & Chin-Yee, B. (2024) · PLOS ONE · doi:10.1371/journal.pone.0306749 · Cited by 11
Metadata
- Authors
- Tangamornsuksan, W., Chaiyakunapruk, N., Somkrua, R., Lohitnavy, M., & Tassaneeyakul, W.
- Venue
- JAMA Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2013-09-01
- Volume
- 149
- Issue
- 9
- Pages
- 1025
- ISSN
- 2168-6068 (ISSN-L)
- OpenAlex
- W2020336128
- Cited by
- 263
- References
- 37
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.